Multidrug-resistant
Multidrug-resistant (MDR) refers to the phenomenon where a microorganism or cancer cell develops resistance to multiple antimicrobial drugs or chemotherapy drugs, respectively. This resistance can occur through various mechanisms, including alterations in the target site of the drug, decreased drug uptake, increased drug efflux, or enzymatic degradation of the drug.
Mechanisms of Multidrug Resistance[edit | edit source]
The mechanisms of multidrug resistance in microorganisms and cancer cells are complex and multifactorial. They can be broadly classified into four categories:
- Alterations in the target site of the drug: This occurs when the drug target in the cell changes in a way that reduces the drug's effectiveness. For example, in Methicillin-resistant Staphylococcus aureus (MRSA), a change in the target protein PBP2a reduces the effectiveness of beta-lactam antibiotics.
- Decreased drug uptake: This occurs when the cell reduces the amount of drug that enters the cell. This can be due to changes in cell membrane permeability or active transport mechanisms.
- Increased drug efflux: This occurs when the cell increases the amount of drug that is pumped out of the cell. This is often due to the overexpression of efflux pumps, such as the P-glycoprotein in cancer cells.
- Enzymatic degradation of the drug: This occurs when the cell produces enzymes that can break down the drug, rendering it ineffective. For example, beta-lactamase enzymes produced by some bacteria can break down beta-lactam antibiotics.
Implications of Multidrug Resistance[edit | edit source]
Multidrug resistance has significant implications for the treatment of infectious diseases and cancer. It can lead to treatment failure, increased healthcare costs, and increased mortality. In the case of infectious diseases, it can also lead to the spread of drug-resistant infections.
Prevention and Management of Multidrug Resistance[edit | edit source]
Prevention and management of multidrug resistance involve a combination of strategies, including appropriate use of antimicrobial and chemotherapy drugs, infection control measures, surveillance of drug resistance, and research into new drugs and treatment strategies.
See Also[edit | edit source]
- Antimicrobial resistance
- Chemotherapy resistance
- Drug resistance in cancer
- Drug resistance in tuberculosis
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD